BIOSTEM TECHNOLOGIES - FILES PROSPECTUS FOR RESALE OF UP TO 2.2 MLN SHARES BY SELLING STOCKHOLDERS - SEC FILING

Reuters · 10/02 21:28

Please log in to view news